SCHEMBL5193591

SCHEMBL5193591

CCCCC(O)CC(=O)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.53
KMT2A Q03164 3/20 0.50
MEN1 O00255 2/20 0.50
NPC1 O15118 1/20 0.50
TSHR P16473 1/20 0.50
GPR84 Q9NQS5 4/20 0.49
CES1 P23141 3/20 0.46
CES2 O00748 2/20 0.46
DRD3 P35462 1/20 0.46
L3MBTL1 Q9Y468 4/20 0.45
MAPT P10636 3/20 0.45
LMNA P02545 2/20 0.45
HPGD P15428 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TDP1 Q9NUW8 2/20 0.44
POLB P06746 1/20 0.44
HTT P42858 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8471030 0.95 GPR84 (0.56) DPP4KMT2AMEN1NPC1TSHR
SCHEMBL8473581 0.93 GPR84 (0.59) DPP4KMT2AMEN1NPC1TSHR
SCHEMBL27868596 0.93 GPR84 (0.59) DPP4KMT2AMEN1NPC1TSHR
SCHEMBL9828678 0.91 DPP4 (0.46) DPP4KMT2AMEN1NPC1TSHR
SCHEMBL10420359 0.89 DPP4 (0.55) DPP4KMT2AMEN1NPC1TSHR
SCHEMBL7857050 0.85 L3MBTL1 (0.52) KMT2ANPC1CES1CES2L3MBTL1
SCHEMBL5196375 0.83 KMT2A (0.50) KMT2AMEN1NPC1TSHRCES1
SCHEMBL27906659 0.82 KMT2A (0.46) KMT2AMEN1NPC1TSHRCES1
SCHEMBL11768086 0.82 TSHR (0.57) DPP4KMT2AMEN1NPC1TSHR
SCHEMBL5194458 0.81 KMT2A (0.49) KMT2AMEN1NPC1TSHRCES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1403260-B1 Optically active epoxy compounds and processes for their production TOSOH CORP (JP) 2007-08-08 EP claimed
US-20040063979-A1 Optically active epoxy compounds and processes for their production TOSOH CORPORATION (JP) 2004-04-01 US claimed
EP-1403260-A2 Optically active epoxy compounds and processes for their production Tosoh Corporation (JP) 2004-03-31 EP claimed
EP-1403260-B1 Optically active epoxy compounds and processes for their production TOSOH CORP (JP) 2007-08-08 EP disclosed
US-7169944-B2 Optically active epoxy compounds and processes for their production TOSOH CORPORATION (JP) 2007-01-30 US disclosed
US-20040063979-A1 Optically active epoxy compounds and processes for their production TOSOH CORPORATION (JP) 2004-04-01 US disclosed
EP-1403260-A2 Optically active epoxy compounds and processes for their production Tosoh Corporation (JP) 2004-03-31 EP disclosed
US-4920133-A Quinoline derivatives and use thereof as antagonists of leukotriene D4 RORER PHARMACEUTICAL CORP. (US) 1990-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063979-A1 Optically active epoxy compounds and processes for their production CYP51A1, CYP11B1, PTGES DPP4 4162/4885KMT2A 3888/4885MEN1 2396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.